342 related articles for article (PubMed ID: 31849293)
1. miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance.
Marengo B; Pulliero A; Izzotti A; Domenicotti C
Microrna; 2020; 9(3):187-197. PubMed ID: 31849293
[TBL] [Abstract][Full Text] [Related]
2. The Yin-Yang Regulation of Reactive Oxygen Species and MicroRNAs in Cancer.
R Babu K; Tay Y
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717786
[TBL] [Abstract][Full Text] [Related]
3. Glutathione metabolism in cancer progression and treatment resistance.
Bansal A; Simon MC
J Cell Biol; 2018 Jul; 217(7):2291-2298. PubMed ID: 29915025
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
5. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.
Zhu Z; Du S; Du Y; Ren J; Ying G; Yan Z
J Neurochem; 2018 Jan; 144(1):93-104. PubMed ID: 29105080
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.
Seo HA; Moeng S; Sim S; Kuh HJ; Choi SY; Park JK
Cells; 2019 Dec; 9(1):. PubMed ID: 31861937
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
Colla R; Izzotti A; De Ciucis C; Fenoglio D; Ravera S; Speciale A; Ricciarelli R; Furfaro AL; Pulliero A; Passalacqua M; Traverso N; Pronzato MA; Domenicotti C; Marengo B
Oncotarget; 2016 Oct; 7(43):70715-70737. PubMed ID: 27683112
[TBL] [Abstract][Full Text] [Related]
8. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of NRF2 in ROS-mediated tumor chemoresistance.
Xue D; Zhou X; Qiu J
Biomed Pharmacother; 2020 Nov; 131():110676. PubMed ID: 32858502
[TBL] [Abstract][Full Text] [Related]
10. Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation.
Marengo B; Monti P; Miele M; Menichini P; Ottaggio L; Foggetti G; Pulliero A; Izzotti A; Speciale A; Garbarino O; Traverso N; Fronza G; Domenicotti C
Sci Rep; 2018 Sep; 8(1):13762. PubMed ID: 30213983
[TBL] [Abstract][Full Text] [Related]
11. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
[TBL] [Abstract][Full Text] [Related]
12. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.
Ismail T; Kim Y; Lee H; Lee DS; Lee HS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500275
[TBL] [Abstract][Full Text] [Related]
13. Role of Glutathione in Cancer: From Mechanisms to Therapies.
Kennedy L; Sandhu JK; Harper ME; Cuperlovic-Culf M
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050144
[TBL] [Abstract][Full Text] [Related]
14. The differential role of reactive oxygen species in early and late stages of cancer.
Assi M
Am J Physiol Regul Integr Comp Physiol; 2017 Dec; 313(6):R646-R653. PubMed ID: 28835450
[TBL] [Abstract][Full Text] [Related]
15. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
16. Curcumin as a MicroRNA Regulator in Cancer: A Review.
Momtazi AA; Shahabipour F; Khatibi S; Johnston TP; Pirro M; Sahebkar A
Rev Physiol Biochem Pharmacol; 2016; 171():1-38. PubMed ID: 27457236
[TBL] [Abstract][Full Text] [Related]
17. miRNAs, oxidative stress, and cancer: A comprehensive and updated review.
Ebrahimi SO; Reiisi S; Shareef S
J Cell Physiol; 2020 Nov; 235(11):8812-8825. PubMed ID: 32394436
[TBL] [Abstract][Full Text] [Related]
18. Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis.
Wang SF; Wung CH; Chen MS; Chen CF; Yin PH; Yeh TS; Chang YL; Chou YC; Hung HH; Lee HC
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380689
[TBL] [Abstract][Full Text] [Related]
19. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
20. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
Butturini E; Carcereri de Prati A; Chiavegato G; Rigo A; Cavalieri E; Darra E; Mariotto S
Free Radic Biol Med; 2013 Dec; 65():1322-1330. PubMed ID: 24095958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
